Image Source:
Momentum Shifts to Tech and Big BIopharma Stocks in 2024
Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD.
Widely held United Health (UNH) is down 4.35% YTD. IHF Providers ETF is down 2% YTD.
Medtech starting to recover from the “Ozempic Effect”.
The nascent bull market is intact with many sectors doing well YTD as investors shift their perspective to upcoming earnings reports and guidance for 2024. The momentum trade in small caps faded through #JPM24 despite a pick-up in M&A. And UNH down 4.35% YTD the mainstay of many healthcare portfolios and funds was rocked by . But diversification helped because the Financial sector () is up 0.88% YTD, the Industrials () up 2.3% YTD, and the S&P () up 1.5% YTD. Importantly the TECH sector is coming back with the XLK up 4%YTD and the QQQ up 2.85% YTD. Healthcare stocks have been helped by big biopharma as you can see from some our top picks below: , , , , , and .
Despite some weakness in healthcare stocks the XLV was up 2.26% YTD because of overweight in large cap biopharma and medical devices with some re-balancing with longs in DHR, JNJ, TMO.
Small cap speculative stocks had a nice run as we expected up to JPM24 but not enough fuel to keep momentum intact as you can see by the XBI down 2.5% YTD. Similarly, we see falling 12.13% YTD. We traded out of both of these ETFs and they can be the bellwether of what’s to come with small cap biotechs. Among SMID biotechs holding values since early October: , , , . The is waning up only 0.49% YTD.We added to MedtTech with and more speculative medical device small caps as we expect procedure utilization and testings will pick up as reported by hospitals and insurers. Note that is up 4.2% YTD. A few months ago there were reports that because of the wide of popularity of GLP-1 agonist obesity drugs from Lilly and Novo-Nordisk, there would be lower utllizatioon of medical care so watch for this trend.
But the big story so far in 2024 is your portfolio needs to be overweight TECH because of AI, DATA centers and demand for semiconductors.
| Model |
|
|
|
|
|
|
|
|
|
|
|
|
| PORTFOLIO |
|
|
|
|
|
* |
|
|
|
|
|
|
| |
|
2020 |
|
2020 |
2020 |
2021 |
2022 |
2023 |
2024 |
|
5 yr % Total Ret
|
|
| Stock/ETF |
Ticker |
Price |
Wgt |
Price |
|
Price |
Price |
Price |
P |
|
|
|
| |
|
10/25 |
% |
12/31 |
% Perf |
12/31/21 |
12/31/22 |
11/11 |
1/21 |
%Perf |
% |
|
| |
|
|
|
|
|
|
|
P |
|
YTD |
|
|
| iShares NAZ Bio |
IBB |
136 |
10 |
151.5 |
25.7 |
152.62 |
130.55 |
115.53 |
135.18 |
0.49 |
22.37 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| iShares Russell 2k |
IWM |
163 |
5 |
196.4 |
18.3 |
222.45 |
174.36 |
175 |
192.43 |
-4.13 |
30.61 |
|
| Merck* |
MRK |
80 |
10 |
81.77 |
-10 |
76.64 |
115 |
101.39 |
118.89 |
9.05 |
64.22 |
|
| United Health |
UNH |
330 |
15 |
350.7 |
27.19 |
502 |
530.27 |
541.21 |
503.56 |
-4.35 |
89.66 |
|
| SPDR S&P Bio |
XBI |
117 |
5 |
140.8 |
48 |
111.96 |
83 |
66.95 |
87.05 |
-2.51 |
4.4 |
|
| Healthcare SPDR |
XLV |
108 |
20 |
113.4 |
14.71 |
140.89 |
135.88 |
126.27 |
139.46 |
2.26 |
54.82 |
|
| T.Rowe Hlth Sci |
PRHSX |
n/a |
10 |
99.65 |
n/a |
104 |
89 |
83.41 |
88.45 |
0.67 |
20.35 |
|
| iShares U.S MedT |
IHI |
50 |
10 |
54.83 |
|
65.85 |
52.57 |
45.75 |
55.4 |
2.65 |
57.44 |
|
| MedTech* |
ABT |
|
5 |
123.5 |
|
127.46 |
109.83 |
93.97 |
114.69 |
4.2 |
60.59 |
|
| |
|
|
|
|
|
peak yr |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Tracking Comp |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| ARK Genomic |
ARKG |
|
|
93.26 |
|
61.24 |
28.23 |
24.1 |
28.83 |
-12.13 |
– |
|
| Direx3X Bull |
LABU |
|
|
|
|
|
7.66 |
2.74 |
110.89 |
-9.08 |
-88.86 |
r split? |
| FIDO Biotech |
FBIOX |
** |
|
25.18 |
|
19.35 |
16.04 |
14.39 |
17.99 |
0.9 |
-10.59 |
|
| FiDO MEDtech |
FSMEX |
|
|
76.15 |
|
83.18 |
60.04 |
51.64 |
62.64 |
1.1 |
24.63 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| DOW |
DIA |
|
|
310 |
|
363.32 |
331.34 |
343 |
378.6 |
0.46 |
53.25 |
|
| S&P 500 |
SPY |
|
|
379 |
|
475 |
382.41 |
440 |
482.43 |
1.5 |
81.05 |
|
| NASDAQ-100 |
QQQ |
|
|
315 |
|
397.85 |
266.33 |
378.39 |
421.18 |
2.85 |
154.87 |
|
| Technology SPDR |
XLK |
|
|
128.93 |
|
161.97 |
124.44 |
179.52 |
200.17 |
4 |
206.3 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Top Biopharmas |
* |
|
|
|
|
|
2022 |
11/11 |
P 1/19 |
% ytd |
5 yr % total |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Abbvie |
ABBV |
* |
|
|
|
|
161.64 |
138.59 |
164.67 |
6.32 |
84.1 |
|
| Astra Zeneca |
AZN |
* |
|
|
|
|
68 |
63.17 |
66.54 |
-1.2 |
82.05 |
|
| Bristol Myers Sq |
BMY |
|
|
|
|
|
71.05 |
50.61 |
50.11 |
-2.34 |
– |
|
| Gilead Sci |
GILD |
|
|
|
|
|
85.39 |
75.92 |
87.29 |
7.79 |
26.19 |
|
| Eli Lilly |
LLY |
* |
|
|
|
|
447.71 |
597.71 |
628.58 |
7.83 |
439.14 |
|
| Merck |
MRK |
* |
|
|
|
|
110.95 |
101.39 |
118.89 |
9.05 |
64.22 |
|
| Pfizer |
PFE |
* |
|
|
|
|
51.24 |
29.48 |
28.28 |
-1.77 |
-29.91 |
|
| Regeneron |
REGN |
* |
|
|
|
|
725 |
798.94 |
933.4 |
6.27 |
122.85 |
|
| Vertex |
VRTX |
* |
|
|
|
|
288.78 |
373.65 |
435.02 |
6.91 |
122.43 |
More By This Author:
